foxo4-dri 10mg FOXO4-DRI 10mg vial - Description

5,10-Methylene tetrahydrofolate (THF) is required for the synthesis of nucleic acids and is reduced to 5-methyl THF by methylene THF reductase, a flavin-dependent enzyme that uses NADPH as a cofactor

These are ranges seen across research-supply listings in 2026, not a quote from any single vendor

RNA sequencing and pathway enrichment analysis show FOXO4-DRI significantly downregulates extracellular matrix-receptor interaction pathways, including fibronectin (Fn1), tenascin C (Tnc), and thrombospondin 2 (Thbs2), all critical components of fibrotic tissue architecture

A 50 mg vial will generally cost around $250

Many compounds that produce extraordinary results in preclinical models fail to replicate those outcomes in human clinical trials